In your state
Minnesota

In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.

Economic Impact In Your State: Minnesota

$9.8B

Total output supported by biophamaceutical sector

$503,821

Total output supported by biophamaceutical sector

40,111

Total Jobs

7,600

Direct Jobs

Clinical Trials in Your State: Minnesota

653

TOTAL CLINICAL TRIALS

$218 million

INVESTED IN CLINICAL TRIALS

13,942

TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS

$629.8 million

INVESTED IN CLINICAL TRIALS

Programs and Initiatives in Your State: Minnesota

State programs and initiatives to promote biopharmaceutical industry development

    ACCELERATING INNOVATION, COMMERCIALIZATION & ENTREPRENEURIAL DEVELOPMENT

    BUILDING ADVANCED MANUFACTURING

    BUILDING RESEARCH CAPACITY AND/OR R&D INFRASTRUCTURE

    ECONOMIC INNOVATION INCENTIVES

    STEM EDUCATION & WORKFORCE DEVELOPMENT

    TARGETED STRATEGIES

    VENTURE FINANCING

State Innovation Indicators

29

Patents per 1,000 people in Science & Engineering

9%

Percentage of Workforce Employed in High-Tech Jobs